FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and represents a nutritional composition for an infant or: : a child containing lipid or fat, a protein source, a source of long-chain polysaturated fatty acids which contains docosahexaenoic acid; a supplementary calcium source to 2.5 wt % with at least 20% of the supplementary calcium source representing calcium gluconate, and PDGF-β 0.015 to 0.1 ppm (pg/mcg).
EFFECT: provided better digestibility as compared to the conventional compositions.
12 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NUTRITIONAL COMPOSITION PROMOTING NORMAL DEVELOPMENT AND GROWTH | 2009 |
|
RU2508121C2 |
| STAGEWISE BABY FEEDING REGIME FOR PROMOTION OF HEALTHY DEVELOPMENT AND GROWTH | 2011 |
|
RU2575747C2 |
| ENDOGENIC TGF-BETA PRESERVATION METHODS | 2009 |
|
RU2547590C2 |
| APPLICATION OF LACTOFERRIN-CONTAINING NUTRITIONAL COMPOSITIONS FOR STIMULATION OF IMMUNE CELLS | 2011 |
|
RU2575776C2 |
| NUTRITIONAL COMPOSITIONS | 2011 |
|
RU2541396C2 |
| LIQUID COMPOSITION OF MILK ENRICHING AGENT WITH RELATIVELY HIGH CONTENT OF LIPIDS | 2013 |
|
RU2685187C2 |
| COMPOSITIONS AND METHODS FOR PRODUCTION OF ENTERAL FORMULAS CONTAINING SIALIC ACID | 2004 |
|
RU2361408C2 |
| COMPOSITION CONTAINING HUMAN MILK OLIGOSACCHARIDES USED FOR INFANTS AND YOUNG CHILDREN TO PREVENT OR TREAT ALLERGIES | 2017 |
|
RU2744199C2 |
| SET OF AGE-APPROPRIATE INFANT FORMULAS WITH OPTIMAL PROTEIN CONTENT AND LACTOSE CONTENT | 2014 |
|
RU2708975C1 |
| COMPOSITION, CONTAINING THERMOLABILE MILK PROTEINS AND METHOD FOR OBTAINING THEREOF | 2011 |
|
RU2575178C2 |
